Heart & Lung: The Journal of Acute and Critical Care
Volume 36, Issue 5 , Pages 380-382 , September 2007

Staphylococcus hominis native mitral valve bacterial endocarditis (SBE) in a patient with hypertrophic obstructive cardiomyopathy

  • Burke A. Cunha, MD

      Affiliations

    • Winthrop-University Hospital, Mineola, New York
    • State University of New York School of Medicine, Stony Brook, New York.
    • Corresponding Author InformationReprint requests: Burke A. Cunha, MD, Infectious Disease Division, Winthrop-University Hospital, Mineola, NY 11501.
    • ,
  • Michael D. Esrick, MD

      Affiliations

    • Winthrop-University Hospital, Mineola, New York
    • ,
  • Melissa LaRusso, DO

      Affiliations

    • Winthrop-University Hospital, Mineola, New York

References 

  1. Miele PS, Kogulan PK, Levy CS, et al. Seven cases of surgical native valve endocarditis caused by coagulase-negative staphylococci: an underappreciated disease. Am Heart J. 2001;142:571–576
  2. Etienne J, Eykyn SJ. Increase in native valve endocarditis caused by coagulase negative staphylococci: an Anglo-French clinical and microbiological study. Br Heart J. 1990;64:381–384
  3. Von Eiff C, Peters G, Heilmann C. Pathogenesis of infections due to coagulase-negative Staphylococci. Lancet Infect Dis. 2002;2:677–685
  4. Zinkernagel AS, Speck RF, Ruef C, et al. Rapidly destructive staphylococcus epidermidis endocarditis. Infection. 2005;33:148–150
  5. Caputo GM, Archer GL, Calderwood SB, et al. Native valve endocarditis due to coagulase-negative staphylococci: critical and microbiological features. Am J Med. 1987;83:619–625
  6. Chu VH, Cabell CH, Abrutyn E, et al. Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the international collaboration on endocarditis merged database. Clin Infect Dis. 2004;39:1527–1530
  7. In:  Weinstein L,  Brusch JL editor. Infective Endocarditis. New York: Oxford University Press, Inc; 1996;
  8. Cunha BA, Gill V, Lazar J. Acute infective endocarditis: diagnostic and therapeutic approach. Infect Dis Clin North Am. 1996;10:811–834
  9. Roberts WC, Kishel JC, McIntosh CL, et al. Severe mitral or aortic valve regurgitation, or both, requiring valve replacement for infective endocarditis complicating hypertrophic cardiomyopathy. J Am Colleg Cardiol. 1992;19:365–371
  10. Maron MS, Olivotto I, Betocchi S, et al. Effect of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. N Engl J Med. 2003;348:295–303
  11. Spirito P, Rapezzi C, Bellon P, et al. Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence, and indication for antibiotic prophylaxis. Circulation. 1999;99:2132–2137
  12. Kessler RB, Kimbrough RC, Jones SR. Infective endocarditis caused by Staphylococcus hominis after vasectomy. Clin Infect Dis. 1998;27:216–217
  13. Morgan-Hughes G, Motwani J. Mitral valve endocarditis in hypertrophic cardiomyopathy: case report and literature review. Heart. 2002;87:e8
  14. Cunha BA. S. aureus bacteremia: clinical therapeutic guidelines. Antibiotic for Clinicians. 2006;10:365–367
  15. Cunha BA. Persistent S. aureus bacteremia: a clinical pathway for diagnosis & treatment. Antibiotic for Clinicians. 2006;10(S1):39–46

PII: S0147-9563(07)00004-0

doi: 10.1016/j.hrtlng.2006.11.002

Heart & Lung: The Journal of Acute and Critical Care
Volume 36, Issue 5 , Pages 380-382 , September 2007

Article Tools